Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025)
Aclaris Therapeutics (ACRS) recorded quarterly Prepaid Assets of $4.2 million in Q2 2025, up 30.25% quarter-over-quarter from $3.2 million in Q1 2025, and down 32.41% on a YoY basis from $6.2 million in Q2 2024.
Aclaris Therapeutics (ACRS) Prepaid Assets (2014 - 2025) Analysis & Trends
Aclaris Therapeutics' Prepaid Assets history runs 12 years deep, the most recent figure standing at $4.2 million for Q2 2025.
- In Q2 2025, Prepaid Assets fell 32.41% year-over-year to $4.2 million; the TTM figure through Jun 2025 stood at $4.2 million (down 32.41% YoY), while the FY2024 annual figure was $12.0 million, up 27.37% from the prior year.
- Prepaid Assets was $4.2 million for Q2 2025 at Aclaris Therapeutics, up from $3.2 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $19.7 million in Q3 2023 to a low of $3.2 million in Q1 2025.
- Historically, Prepaid Assets has averaged $9.3 million across 5 years, with a median of $9.0 million in 2021.
- The sharpest annual moves came in 2021 and 2024: Prepaid Assets surged 401.74% in 2021, then sank 78.32% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $13.0 million in 2021, then increased by 3.85% to $13.5 million in 2022, then dropped by 29.96% to $9.5 million in 2023, then gained by 27.37% to $12.0 million in 2024, then sank by 65.1% to $4.2 million in 2025.
- The last three Prepaid Assets figures came in at $4.2 million (Q2 2025), $3.2 million (Q1 2025), and $12.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Aclaris Therapeutics | 580.93 Mn | 580.93 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 3.23 Mn |
| Dec 31, 2024 | 12.04 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 6.22 Mn |
| Mar 31, 2024 | 6.80 Mn |
| Dec 31, 2023 | 9.45 Mn |
| Sep 30, 2023 | 19.67 Mn |
| Jun 30, 2023 | 12.73 Mn |
| Mar 31, 2023 | 12.87 Mn |
| Dec 31, 2022 | 13.50 Mn |
| Sep 30, 2022 | 7.91 Mn |
| Jun 30, 2022 | 10.11 Mn |
| Mar 31, 2022 | 10.63 Mn |
| Dec 31, 2021 | 13.00 Mn |
| Sep 30, 2021 | 7.09 Mn |
| Jun 30, 2021 | 8.65 Mn |
| Mar 31, 2021 | 5.39 Mn |
| Dec 31, 2020 | 2.59 Mn |
| Sep 30, 2020 | 1.88 Mn |